Lauren Barnes

Lauren (Geyer) Barnes is a seasoned professional in the healthcare and pharmaceutical industries, currently serving as Senior Vice President of Strategic Market Development & Access at Blueprint Medicines since April 2019, with responsibilities encompassing Business Insights and Analytics, New Product Planning, and Competitive Intelligence. Additionally, Lauren holds the position of Senior Vice President of Market Access at Ossium and has been a Board Member at Ascelia Pharma AB since May 2020, where also serves as Chair of the Commercialization Committee. Past leadership roles include serving as the Past Chair of the Board of Directors for the Cancer Support Community from 2020 to 2023 and significant positions at Vertex Pharmaceuticals and Avalere Health, where strategic market access and product commercialization were key focuses. Lauren's earlier career includes director-level roles at Amgen and the Centers for Medicare & Medicaid Services, alongside foundational experience as a Senior Scientist at Vector Research. Educational credentials include a Master of Health Science in Health Policy and a Bachelor's degree in Public Health from The Johns Hopkins University.